Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain

Neurobiol Aging. 2003 Nov;24(7):921-6. doi: 10.1016/s0197-4580(03)00013-7.

Abstract

Two different polymorphic regions of the interleukin-6 (IL-6) gene were investigated in patients with Alzheimer's disease (AD) and non-demented controls. The -174 C allele in the promoter region of IL-6 gene was over-represented in AD patients compared to controls and significantly increased the risk of AD. Moreover, the -174 CC genotype was associated with a high risk of the disease in women. The D allele of a variable number of tandem repeat (VNTR) was in strong linkage disequilibrium with the -174 C allele and slightly increased AD risk. On the other hand, the frequency of the VNTR C allele was decreased in patients with AD and was negatively associated with the risk of developing AD. Both the -174 CC and VNTR DD genotypes were also associated with increased IL-6 levels in the blood and brain from AD. These findings suggest that IL-6 may play a multifaceted role in AD by affecting the turnover of the cytokine.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3' Flanking Region
  • Aged
  • Aging / genetics*
  • Alzheimer Disease / blood
  • Alzheimer Disease / genetics*
  • Analysis of Variance
  • Apolipoprotein E4
  • Apolipoproteins E / genetics
  • Female
  • Frontal Lobe / physiopathology*
  • Gene Frequency / genetics*
  • Genetic Predisposition to Disease
  • Humans
  • Interleukin-6 / blood
  • Interleukin-6 / genetics*
  • Italy
  • Linkage Disequilibrium / genetics
  • Male
  • Middle Aged
  • Minisatellite Repeats / genetics
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic
  • Reference Values
  • Risk Factors
  • Sex Factors

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • Interleukin-6